Persistent clonal chromosomal abnormalities in a chronic myeloid leukemia patient

被引:1
作者
Muraoka, Michiko [1 ]
Washio, Kana [1 ]
Kanamitu, Kiichiro [1 ]
Kanazawa, Yui [1 ]
Ishida, Toshiaki [3 ]
Miyamura, Takako [4 ]
Chayama, Kosuke [5 ]
Nishiuchi, Ritsuo [6 ]
Oda, Megumi [2 ]
Shimada, Akira [1 ]
机构
[1] Okayama Univ, Grad Sch Med, Dept Pediat, Okayama, Japan
[2] Okayama Univ Hosp, Dept Pediat Hematol & Oncol, Okayama, Japan
[3] Hyogo Childrens Hosp, Dept Hematol Oncol, Kobe, Hyogo, Japan
[4] Osaka Univ Hosp, Dept Pediat, Osaka 553, Japan
[5] Toyonaka City Hosp, Dept Pediat, Osaka, Japan
[6] Kochi Hlth Sci Ctr, Dept Pediat, Kochi, Japan
关键词
chromosome instability; chronic myelogenous leukemia; clonal chromosome abnormality; imatinib; PHILADELPHIA-CHROMOSOME; NEGATIVE CELLS; THERAPY; ABERRATIONS; MECHANISMS; BIOLOGY; DISEASE;
D O I
10.1111/ped.12739
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Clonal cytogenetic abnormalities (CCA) in Philadelphia chromosome (Ph)-negative cells have been reported in a small population of adult chronic myelogenous leukemia (CML) patients during the clinical course, but CCA in pediatric CML patients are rarely reported. We herein report the case of an 8-year-old boy from the onset of CML. Although he had relapse after unrelated bone marrow transplantation when 9years old, he has since been in complete molecular response on imatinib mesylate treatment. Surprisingly, various CCA have been observed in this patient, including several reciprocal chromosomal translocations in Ph-negative cells for >12years. Although dysplasia in the bone marrow cells was identified, no overt transformation to myelodysplastic syndrome or acute myeloid leukemia has been observed. The cause of the CCA remains unknown in this patient, and careful observation is required.
引用
收藏
页码:53 / 56
页数:4
相关论文
共 10 条
  • [1] CLONAL ORIGIN OF PHILADELPHIA-CHROMOSOME NEGATIVE CELLS WITH TRISOMY-8 APPEARING DURING THE COURSE OF ALPHA-INTERFERON THERAPY FOR PH POSITIVE CHRONIC MYELOCYTIC-LEUKEMIA
    ARIYAMA, T
    INAZAWA, J
    UEMURA, Y
    KAKAZU, N
    MAEKAWA, T
    URASE, F
    IRIMAJIRI, K
    HORIUCHI, A
    NAKAMURA, Y
    ABE, T
    [J]. CANCER GENETICS AND CYTOGENETICS, 1995, 81 (01) : 20 - 23
  • [2] Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
    Baccarani, Michele
    Cortes, Jorge
    Pane, Fabrizio
    Niederwieser, Dietger
    Saglio, Giuseppe
    Apperley, Jane
    Cervantes, Francisco
    Deininger, Michael
    Gratwohl, Alois
    Guilhot, Francois
    Hochhaus, Andreas
    Horowitz, Mary
    Hughes, Timothy
    Kantarjian, Hagop
    Larson, Richard
    Radich, Jerald
    Simonsson, Bengt
    Silver, Richard T.
    Goldman, John
    Hehlmann, Rudiger
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 6041 - 6051
  • [3] The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells
    Deininger, Michael W. N.
    Cortes, Jorge
    Paquette, Ron
    Park, Byung
    Hochhaus, Andreas
    Baccarani, Michele
    Stone, Richard
    Fischer, Thomas
    Kantarjian, Hagop
    Niederwieser, Dietger
    Gambacorti-Passerini, Carlo
    So, Charlene
    Gathmann, Insa
    Goldman, John M.
    Smith, Douglas
    Druker, Brian J.
    Guilhot, Francois
    [J]. CANCER, 2007, 110 (07) : 1509 - 1519
  • [4] Mechanisms of disease - The biology of chronic myeloid leukemia
    Faderl, S
    Talpaz, M
    Estrov, Z
    O'Brien, S
    Kurzrock, R
    Kantarjian, HM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) : 164 - 172
  • [5] EVIDENCE FOR A MULTISTEP PATHOGENESIS OF CHRONIC MYELOGENOUS LEUKEMIA
    FIALKOW, PJ
    MARTIN, PJ
    NAJFELD, V
    PENFOLD, GK
    JACOBSON, RJ
    HANSEN, JA
    [J]. BLOOD, 1981, 58 (01) : 158 - 163
  • [6] Transient presence of clonal chromosomal aberrations in Ph-negative cells in patients with chronic myeloid leukemia remaining in deep molecular response on tyrosine kinase inhibitor treatment
    Gniot, Michal
    Lewandowski, Krzysztof
    Ratajczak, Biraiej
    Lewandowska, Maria
    Lehmann-Kopydlowska, Agata
    Jarmuz-Szymczak, Mafgorzata
    Komarnicki, Mieczyslaw
    [J]. CANCER GENETICS, 2014, 207 (10-12) : 503 - 510
  • [7] Mechanisms of disease - Chronic myeloid leukemia - Advances in biology and new approaches to treatment
    Goldman, JM
    Melo, JV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (15) : 1451 - 1464
  • [8] HEINZE B, 1995, STEM CELLS, V13, P191
  • [9] Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase
    Jabbour, Elias
    Kantarjian, Hagop M.
    Abruzzo, Lynne V.
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Verstovsek, Srdan
    Shan, Jianqin
    Rios, Mary Beth
    Cortes, Jorge
    [J]. BLOOD, 2007, 110 (08) : 2991 - 2995
  • [10] Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia
    Zaccaria, Alfonso
    Valenti, Anna Maria
    Donti, Emilio
    Gozzetti, Alessandro
    Ronconi, Sonia
    Spedicato, Francesco
    [J]. HAEMATOLOGICA, 2007, 92 (04) : 564 - 565